Nanoscope Therapeutics Partners With McKesson for Retinal Therapy
DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...
COLUMBUS, Ohio, May 13, 2026 Andelyn Biosciences announced that it has received full certification under the Initiative for Certification...
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
LEBANON, Indiana, United States – May 6, 2026 Eli Lilly and Company has announced an additional $4.5 billion investment...
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
BOSTON, Feb. 23, 2026 — Haemonetics Corporation announced that the U.S. Food and Drug Administration granted 510(k) clearance for...
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
Santa Monica, California — February 6, 2026 Kite, a Gilead Company, has announced that the U.S. Food and Drug...
Miami, Florida — February 6, 2026 CaseBioscience® has announced the launch of CaseCryo® CTG DMSO and CaseStor® HSS Hypothermic...
Rockville, Md. and Shanghai, January 18, 2026 — AbelZeta Pharma, Inc. announced that AstraZeneca has agreed to acquire AbelZeta’s...
